Contineum Therapeutics CTNM
NASDAQ CTNM
$10.77 +0.21 (+1.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Contineum Therapeutics (CTNM) Other financing activities (as filed) (2024 - 2026)

Updated

Contineum Therapeutics (CTNM) recorded Other financing activities (as filed) of $64,000 in Q3 2026, compared with -$80,000 a year earlier.

Analysis

Contineum Therapeutics (CTNM) Other financing activities (as filed) (2024 - 2026) Analysis & Trends

On a TTM basis, Contineum Therapeutics' Other financing activities (as filed) came in at -$58,000 as of Sep 30, 2026; for FY2025, it was -$256,000.

  • Across earlier years, Other financing activities (as filed) came in at -$343,000 in FY2023.
  • The Q3 2026 figure is the highest quarterly Other financing activities (as filed) since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Contineum Therapeutics 405.40 Mn -584.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 64,000.00
Jun 30, 2026 -53,000.00
Mar 31, 2026 -69,000.00
Sep 30, 2025 -80,000.00
Jun 30, 2025 -176,000.00
Jun 30, 2024 140,000.00
Mar 31, 2024 -140,000.00
API Access

Contineum Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CTNM&period=max&api_key=YOUR_API_KEY